By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Robotic surgery, also known as robot-assisted surgery, enables surgeons to perform a wide range of complex procedures with better precision, flexibility, and control than traditional techniques allow.
Robotic surgery is frequently associated with minimally invasive surgery, which uses tiny incisions. It’s also used in some traditional open surgical procedures.
The most popular clinical robotic surgical system combines a camera arm with mechanical arms that are equipped with surgical instruments.
The surgeon controls the arms from a computer station adjacent to the operating table. The console displays a high-resolution, magnified 3D image of the surgical site to the surgeon.
The surgeon directs the other members of the team who assist with the surgery.
Surgical robots are useful for minimally invasive surgery because they allow for precise manipulation of surgical equipment that humans in a small operating room cannot.
Using this technology, they created a miniature manipulator for minimally invasive neurosurgery.
The micro manipulator is made up of two small grasping manipulators, a rigid neuroendoscopy, a suction tube, and a perfusion tube. This research focuses on the small grasping manipulator.
Among the specialties that provide robotic-assisted surgery are GI, cardiothoracic, gynecologic oncology, otolaryngology (head and neck), and urologic surgery.
Each treatment is performed by a highly skilled and experienced team of surgeons, nurses, and technicians who have received special training in the use of robotic surgical equipment.
Memory devices are crucial in preventing difficulties during robot-assisted surgery. Memory storage systems can play a number of functions based on the patient’s physical record.
They may also display specific information to check calibration offsets showing storage drive system misalignment, data life, and so on.
The Canada Surgical Robotics Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Medtronic Canada ULC, a subsidiary of Medtronic plc, has acquired a Health Canada license for the Hugo robotic-assisted surgery (RAS) system for use in urologic and gynecologic laparoscopic surgical procedures, which account for over half of all robotic operations performed today.
Hugo RAS is a modular, multi-quadrant platform indicated for urologic and gynecologic laparoscopic surgical procedures.
It combines wristed instruments, 3D visualization, and a cloud-based surgical video capture option in Touch Surgery Enterprise with dedicated support teams specializing in robotics programme optimisation, service, and training.
Health Canada licensing follows important milestones in the Hugo RAS system’s worldwide debut, including CE Mark clearance and the first urologic and gynecologic cases, all of which are included in the Hugo RAS system patient registry.
Hugo RAS is commercially accessible in select regions. Individual nations and regions regulatory criteria will dictate approval, clearance, and market availability.
Touch Surgery Enterprise is not designed to direct surgery or to help in the diagnosis or treatment of a disease or condition.
The da Vinci Surgical System is a tele-manipulation system in which the operating surgeon uses master handles to guide three or four surgical arms from a computer video console while reclining close to the patient.
Patients may benefit from robot-assisted surgery using the da Vinci System because of the use of minimally invasive procedures, which may result in less blood loss, less blood transfusion, fewer problems, less postoperative discomfort, shorter hospital stays, and faster recovery times.
Surgeons may also benefit from increased ergonomics for example, three-dimensional visualization and flexibility, as well as the intuitiveness of movement-enabled eye-hand synchronization, which may be lost in laparoscopic surgery, potentially leading to greater surgical performance.
However, robot-assisted surgery is coupled with substantial capital and operational expenditures.
